This webinar is intended for scientists, computational chemists, and R&D leaders interested in practical strategies for integrating LLMs and agentic workflows into modern drug discovery programs. These AI tools are rapidly evolving from research curiosities into collaborative partners that help chemists summarize literature, analyze PDB structures, propose hypotheses, and coordinate analyses across multiple tools in real time. The session will show how such advances are reshaping medicinal chemistry while preserving scientific rigor and interpretability.
Jeff Blaney, PhDSr. Director, Discovery Chemistry at Genentech
Jeff Blaney, PhD is Sr. Director of Discovery Chemistry at Genentech, where he leads research efforts in computational and medicinal chemistry with a focus on integrating AI and data-driven methods into drug discovery workflows. He has held leadership roles at Genentech for over 17 years, including serving as Head of SMDD AI within Discovery Chemistry. Prior to joining Genentech, Dr. Blaney was VP of Computational Chemistry & Crystallography at SGX Pharmaceuticals, Exec Director of Physical & Chemical Sciences at DuPont Pharmaceuticals, VP of Computational Chemistry at Metaphorics, and Director of Computational Chemistry at Chiron.
Dr. Blaney earned his PhD in Pharmaceutical Chemistry from the University of California, San Francisco, and a BA in Chemistry-Zoology from Pomona College. He has extensive experience in computational chemistry, AI-enabled drug discovery, and advancing small molecule programs through early-stage development.
Garry Pairaudeau, PhDCEO and Co-Founder at Dalton Tx
Garry Pairaudeau, PhD is CEO and Co-Founder of Dalton Tx, where he leads efforts to apply technology, innovation, and AI-driven strategies to accelerate drug discovery. Previously, he served as Chief Technology Officer at Exscientia, focusing on integrating artificial intelligence, machine learning, and automation into medicinal chemistry and development workflows. Prior to that, Dr. Pairaudeau held multiple senior leadership roles at AstraZeneca, including Head of Hit Discovery, Head of External Sciences, and Global Head of Research Outsourcing, where he directed large-scale teams across chemistry, screening, and discovery partnerships.
Dr. Pairaudeau earned his PhD in Chemistry from the University of Southampton, where he also completed his BSc in Chemistry with first-class honors. He brings more than 30 years of experience in drug discovery across both large pharma and biotech, with a proven track record of building high-performing teams and advancing innovative approaches to deliver medicines more effectively.
James White, PhDCollaborative Communications at Collaborative Drug Discovery (CDD)
James White is Director of Collaborative Communications at Collaborative Drug Discovery (CDD Vault), focusing on scientific communication and digital media solutions for biotechnology research organizations. Previously, he served as Associate at Ropes & Gray and Project Manager at Hera Health Solutions, where he developed venture capital networking platforms and provided support for defense grant applications. He completed his PhD in Cell and Developmental Biology at Vanderbilt University and holds a BS in Biopsychology, Cognition, and Neuroscience from the University of Michigan. Dr. White has extensive experience in strategic business development, project management, and fostering partnerships within startup ecosystems, with expertise in communicating complex scientific research to diverse audiences. effectively.
Dylan KissaneHost and Director of Editorial at Labiotech
Dylan Kissane is the Director of Editorial at Labiotech. Born and raised in Western Australia, he earned undergraduate degrees in International Studies and Social Science at the University of South Australia before moving to Europe to complete his postgraduate studies. His doctoral research focused on the nexus of complexity theory, chaos theory, and international relations theory, and he earned his Ph.D. in 2010. After several years working as a professor and tertiary education administrator, he left academia to join a small technology startup where he led their content creation team. Later, he worked for a deep tech scale-up company, where he was promoted rapidly from thought leadership manager to Vice President of Marketing. In 2019, he left to launch his own consultancy and has been working independently since then. Beginning in 2023, he started covering selected biopharma partnering conferences and events for Labiotech. In March 2025, he began hosting the Beyond Biotech podcast, and in July 2025, he was appointed Director of Editorial.
"*" indicates required fields